Shares of FibroGen fell by a staggering 62.35% in 30 days from $-43.12 to $19.23 at 10:19 EST on Tuesday, after two consecutive sessions in a row of gains. NASDAQ Composite is falling 0.98% to $13,914.77, following last session’s downward trend, This seems, up until now, a somewhat rough trend exchanging session today.
FibroGen’s last close was $19.91, 197.50% under its 52-week high of $57.21.
The company’s growth estimates for the ongoing quarter and the next is 10.1% and 68.4%, respectively.
Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $19.23 at 10:19 EST, way below its 52-week high of $57.21 and above its 52-week low of $18.95.
FibroGen’s Moving Average
FibroGen’s value is way under its 50-day moving average of $39.14 and way below its 200-day moving average of $42.31.
More news about FibroGen.